$HZNP Headlines Why this year’s rally is not the same

New Post Public Reply Private Reply Replies (0) Message Board

Jul 21, 2014 at 1:07 PM

$HZNP Headlines

Why this year’s rally is not the same as last year’s 2:27 p.m. July 15, 2014 - The Trading Deck
Stocks are poised for a jump higher 12:30 p.m. June 10, 2014 - The Trading Deck
Two health-care names ready to run 12:28 p.m. June 5, 2014 - The Trading Deck
6 stocks to watch 3:13 p.m. June 4, 2014 - The Trading Deck
Charting a bullish second-quarter backdrop 12:34 p.m. April 1, 2014 - Michael Ashbaugh
Charting a bullish second-quarter backdrop 12:20 p.m. April 1, 2014 - Michael Ashbaugh
S&P 500 retests major support 12:47 p.m. March 27, 2014 - Michael Ashbaugh
Thursday’s biggest gaining and declining stocks 4:27 p.m. Sept. 20, 2012 - Greg Morcroft
Horizon Pharma prices offering at steep discount 9:54 a.m. Sept. 20, 2012 - MarketWatch.com
Five companies detail stock offerings 9:39 a.m. Sept. 20, 2012 - MarketWatch.com
Stocks to watch Friday: Goldman, Bally, Scotts 6:54 a.m. Aug. 10, 2012 - MarketWatch
Horizon Pharma down 18% following drug approval 10:59 a.m. July 27, 2012 - Val Brickates Kennedy
Horizon Pharma opens flat post-IPO 12:00 p.m. July 28, 2011 - MarketWatch.com

Biggest Movers in Healthcare Stocks Now – HZNP ARNA GB SGEN 2:15 p.m. July 10, 2014 - InvestorPlace.com
5 Newly Profitable Stocks to Buy – Screen of the Week 6:59 a.m. July 9, 2014 - InvestorPlace.com
A Company's First Profit Can Mean Big Profits to Investors - Screen of the Week 2:11 a.m. July 8, 2014 - Zacks.com
Salix Pharmaceuticals Surges on Positive IBS Data - Analyst Blog 6:15 p.m. July 2, 2014 - Zacks.com
Amgen Gets Breakthrough Therapy Status for Leukemia Drug - Analyst Blog 5:55 p.m. July 2, 2014 - Zacks.com
Hottest Healthcare Stocks Now – IRWD IPXL EXAM HZNP 2:00 p.m. June 19, 2014 - InvestorPlace.com
Horizon finance chief to retire 4:23 p.m. June 18, 2014 - Seeking Alpha
Hard to Find Any Negatives 4:35 p.m. June 17, 2014 - RealMoney.com
Still Churning Higher 1:29 p.m. June 17, 2014 - RealMoney.com
Bear Killers Are on the Hunt 10:22 a.m. June 17, 2014 - RealMoney.com
Hottest Healthcare Stocks Now – EW HZNP PBYI SLXP 7:30 a.m. June 17, 2014 - InvestorPlace.com
Horizon Pharma: Can It Double Again? 4:48 p.m. June 16, 2014 - Seeking Alpha
Why Horizon Pharma (HZNP) Could Be Positioned for a Surge? - Tale of the Tape 8:35 a.m. June 11, 2014 - Zacks.com
Horizon Pharma (HZNP) Stock Has Huge Short Interest: Time to Cover? - Tale of the Tape 9:42 a.m. June 2, 2014 - Zacks.com
Substance Over Style: How Niche Companies Alliqua And Horizon Are Being Overlooked 9:42 a.m. May 29, 2014 - Seeking Alpha
Horizon Pharma (HZNP): An Off-the-Radar Potential Winner - Tale of the Tape 8:57 a.m. May 29, 2014 - Zacks.com
Hottest Healthcare Stocks Now – HZNP MNKD BSX ISIS 1:45 p.m. May 28, 2014 - InvestorPlace.com
Biggest Movers in Healthcare Stocks Now – ISIS CLDX HZNP IDIX 7:45 a.m. May 27, 2014 - InvestorPlace.com
U.S. Firms Pack Up for Tax Benefits 7:36 p.m. May 11, 2014 - The Wall Street Journal Interactive Edition
The 'Inversion' Premium 7:29 p.m. May 11, 2014 - The Wall Street Journal Interactive Edition

Early Briefing on Pharma Stocks -- Research on Novartis, Akorn, Horizon Pharma, and Mallinckrodt 6:50 a.m. July 2, 2014 - PR Newswire - PRF
Market Expansion, Merger Agreements, Management Transitions, and Market Activity - Analyst Notes on Intuitive Surgical, Auxilium, Horizon Pharma, Tesaro and ArQule 6:30 a.m. July 2, 2014 - PR Newswire - PRF
Horizon Pharma Announces Execution of $300 Million Senior Secured Credit Agreement in Connection With the Proposed Acquisition of Vidara 7:01 a.m. June 19, 2014 - Marketwire
Horizon Pharma Announces Robert J. De Vaere to Retire and Names Paul W. Hoelscher Chief Financial Officer 7:01 a.m. June 18, 2014 - Marketwire
Horizon Pharma to Present at the JMP Securities Healthcare Conference 2014 3:25 p.m. June 17, 2014 - Marketwire
Consent Expiry Extensions, Collaborations, Grants, Conference Presentations, and FDA Approvals - Analyst Notes on Forest Laboratories, Intuitive Surgical, Horizon Pharma, Cubist and BDSI 6:10 a.m. June 12, 2014 - PR Newswire - PRF
Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 4:45 p.m. June 6, 2014 - Marketwire
Top Gainers Roundup -- Research on Horizon Pharma, Celldex Therapeutics, Extreme Networks, and WidePoint 6:17 a.m. May 28, 2014 - PR Newswire - PRF
Horizon Pharma to Present at the Jefferies 2014 Global Healthcare Conference 7:31 a.m. May 27, 2014 - Marketwire
Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 5:11 p.m. May 23, 2014 - Marketwire
Financial Results, Acquisition Agreement, and Investor Meeting - Analyst Notes on Zoetis, Horizon Pharma, Akorn, Furiex and Medicines Co. 7:20 a.m. May 16, 2014 - PR Newswire - PRF
Horizon Pharma Reports First Quarter 2014 Financial Results Exceeding Expectations and Raises 2014 Full-Year Guidance 6:31 a.m. May 9, 2014 - Marketwire
Generic Drugs Industry Announces Earnings Results, Leadership Appointments, and Conference Participation - Analyst Notes on Mylan, Zoetis, Hospira, Horizon Pharma and The Medicines Co 8:00 a.m. April 30, 2014 - PR Newswire - PRF
Horizon Pharma to Host Conference Call and Webcast to Discuss First Quarter 2014 Financial Results on May 9, 2014 7:31 a.m. April 25, 2014 - Marketwire
Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 4:36 p.m. April 23, 2014 - Marketwire
Technical Report on Top Gainers -- Research on Centene, Prana Biotechnology, Horizon Pharma, and Scientific Games 11:34 a.m. April 23, 2014 - PR Newswire - PRF
Horizon Pharma Announces the Appointment of H. Thomas Watkins to Its Board of Directors 7:31 a.m. April 17, 2014 - Marketwire
Horizon Pharma Announces Early Termination of Hart-Scott-Rodino Waiting Period for Acquisition of Vidara Therapeutics International Ltd. 7:31 a.m. April 16, 2014 - Marketwire
Recent Acquisitions, Trial Opinions, Upcoming Earnings, Inducement Grants, and Clinical Trial Results - Analyst Notes on Actavis, The Medicines Company, Hospira, Horizon Pharma, and Galectin 8:00 a.m. April 11, 2014 - PR Newswire - PRF
Horizon Pharma Announces the U.S. Patent and Trademark Office Issued an Additional Notice of Allowance With Claims Covering RAYOS(R) (Prednisone) Delayed-Release Tablets 7:31 a.m. April 10, 2014 - Marketwire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PathoSearch: A New Era in Pathology With Visual Search

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Damp or Dry: The Battle for Healthy Air in Colorado

The Hidden Cost of Colorado's Dry Air Dry climate isn't just a seasonal inconvenience—it's a real hidden cost to living comfortably and healthily in Colorado. With winters colder than a brass monkey's tail and summers that don't offer much relief in terms of humidity, your home's air quality is on the front line. So, what's the financial tale here, and how do you come...

Delhi Pushes Innovation Against Dryland Challenges

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

New 2027 Jeep Wrangler JL-2A: A Blast from the Past

Revisiting a Prized Legacy: The 2027 Jeep Wrangler JL-2A Sometimes, what’s new is really just a nod to what’s old—and nowhere is this more so than with the 2027 Jeep Wrangler JL-2A. In the grand parade of automotive history, Jeep's latest creation is more than just a vehicle; it's a time machine that cruises on its historic lineage while strapping on all the modern...

Larry Ellison's Moves Signal Confidence in Oracle's Future

Unraveling Ellison's Bold Decision There's nothing like a sudden shift from a tech titan to make Wall Street sit up and take notice. Today, we got the word that Larry Ellison, Oracle's big gun as Executive Chair and CTO, has pulled the plug on his plan to sell Oracle stock. No dice, no distance covered under that plan. And he's made it crystal clear—selling isn't on his...

PureHealth's Acid Reflux Solutions: An Investor's Insight

Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...

SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Countries Eye New Investment Paths at CIFIT 2026

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

ARTiSTORY's Strategic Advance in Cultural IP Licensing

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

IASLC Boosts Global Thoracic Cancer Collaboration

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...